The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantation.
Sook-Kyoung HeoEui-Kyu NohYoo Jin LeeYerang ShinYoujin KimHyeon-Su ImHyeyeong KimSu Jin KohYoung Joo MinJae-Cheol JoYun Suk ChoiPublished in: BMC cancer (2022)
Higher sVCAM- levels at baseline and on day + 14 in HCT patients could be a significant predictive biomarker of severe aGVHD.